July 02, 2025 FDA Approves Ready-to-Infuse Vancomycin Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis. Conexiant
July 03, 2025 MasSpec Pen Detects Opioids; a Kidney Lipid Atlas; Synthesis Spotlight The Analytical Scientist
June 30, 2025 ASCO 2025: Structured Exercise Program Improves Survival, Outcomes in Some Patients With Colon Cancer The ASCO Post
June 30, 2025 Structured Exercise Program Improves Survival Outcomes in Patients With Stage III or High-Risk Stage II Colon Cancer The ASCO Post
June 30, 2025 Updated Results Confirm Benefit of Combination Regimen in BRAFV600E–Mutated Metastatic Colorectal Cancer The ASCO Post
June 30, 2025 Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K-Mutated Colorectal Cancer The ASCO Post
February 13, 2025 Triplet Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer The ASCO Post
January 27, 2025 Novel Combination Targeted Therapies, Chemotherapy in BRAF-Mutated Metastatic Colorectal Cancer The ASCO Post
July 02, 2025 Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer? Roswell Park Comprehensive Cancer Center
July 01, 2025 When the Hat No Longer Fits: Realigning Roles for a Healthier Practice Optometric Management